SAN DIEGO – December 20, 2018 – ResMed (NYSE: RMD, ASX: RMD) today announced that Mick Farrell, ResMed’s CEO, will present at the 37th Annual J.P. Morgan Healthcare Conference on Monday, January 7, 2019, beginning at approximately 10:00 a.m. (Pacific Time) at the Westin St. Francis in San Francisco, CA.
A live webcast of this event will be available on the investor relations section of ResMed’s website, http://investor.resmed.com. The webcast replay will be available approximately one hour after the live webcast ends and will be accessible for approximately 90 days following the conference.
About ResMed ResMed (NYSE: RMD, ASX: RMD), a world-leading connected health company with more than 6 million cloudconnected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions. Its 6,000-member team strives to improve patients’ quality of life, reduce the impact of chronic disease and save healthcare costs in more than 120 countries. ResMed.com
# # #
For media:
Jayme Rubenstein
+1 858.836.6798
[email protected]
For investors:
Amy Wakeham
+1 858.836.5000
[email protected]